Copyright Reports & Markets. All rights reserved.

Global Drug Preclinical CRO Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Drug Preclinical CRO Services by Type
    • 1.3.1 Overview: Global Drug Preclinical CRO Services Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Drug Preclinical CRO Services Consumption Value Market Share by Type in 2025
    • 1.3.3 Pharmacodynamic evaluation service
    • 1.3.4 Pharmacokinetic Evaluation Service
  • 1.4 Global Drug Preclinical CRO Services Market by Application
    • 1.4.1 Overview: Global Drug Preclinical CRO Services Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Biopharmaceutical Company
    • 1.4.3 Scientific Research Unit
  • 1.5 Global Drug Preclinical CRO Services Market Size & Forecast
  • 1.6 Global Drug Preclinical CRO Services Market Size and Forecast by Region
    • 1.6.1 Global Drug Preclinical CRO Services Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Drug Preclinical CRO Services Market Size by Region, (2021-2032)
    • 1.6.3 North America Drug Preclinical CRO Services Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Drug Preclinical CRO Services Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Drug Preclinical CRO Services Market Size and Prospect (2021-2032)
    • 1.6.6 South America Drug Preclinical CRO Services Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Drug Preclinical CRO Services Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 LabCorp
    • 2.1.1 LabCorp Details
    • 2.1.2 LabCorp Major Business
    • 2.1.3 LabCorp Drug Preclinical CRO Services Product and Solutions
    • 2.1.4 LabCorp Drug Preclinical CRO Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 LabCorp Recent Developments and Future Plans
  • 2.2 IQVIA
    • 2.2.1 IQVIA Details
    • 2.2.2 IQVIA Major Business
    • 2.2.3 IQVIA Drug Preclinical CRO Services Product and Solutions
    • 2.2.4 IQVIA Drug Preclinical CRO Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 IQVIA Recent Developments and Future Plans
  • 2.3 PPD
    • 2.3.1 PPD Details
    • 2.3.2 PPD Major Business
    • 2.3.3 PPD Drug Preclinical CRO Services Product and Solutions
    • 2.3.4 PPD Drug Preclinical CRO Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 PPD Recent Developments and Future Plans
  • 2.4 ICON（PRA）
    • 2.4.1 ICON（PRA） Details
    • 2.4.2 ICON（PRA） Major Business
    • 2.4.3 ICON（PRA） Drug Preclinical CRO Services Product and Solutions
    • 2.4.4 ICON（PRA） Drug Preclinical CRO Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 ICON（PRA） Recent Developments and Future Plans
  • 2.5 Charles River
    • 2.5.1 Charles River Details
    • 2.5.2 Charles River Major Business
    • 2.5.3 Charles River Drug Preclinical CRO Services Product and Solutions
    • 2.5.4 Charles River Drug Preclinical CRO Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Charles River Recent Developments and Future Plans
  • 2.6 WuXi AppTec
    • 2.6.1 WuXi AppTec Details
    • 2.6.2 WuXi AppTec Major Business
    • 2.6.3 WuXi AppTec Drug Preclinical CRO Services Product and Solutions
    • 2.6.4 WuXi AppTec Drug Preclinical CRO Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 WuXi AppTec Recent Developments and Future Plans
  • 2.7 Pharmaron
    • 2.7.1 Pharmaron Details
    • 2.7.2 Pharmaron Major Business
    • 2.7.3 Pharmaron Drug Preclinical CRO Services Product and Solutions
    • 2.7.4 Pharmaron Drug Preclinical CRO Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Pharmaron Recent Developments and Future Plans
  • 2.8 Joinn Laboratories
    • 2.8.1 Joinn Laboratories Details
    • 2.8.2 Joinn Laboratories Major Business
    • 2.8.3 Joinn Laboratories Drug Preclinical CRO Services Product and Solutions
    • 2.8.4 Joinn Laboratories Drug Preclinical CRO Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Joinn Laboratories Recent Developments and Future Plans
  • 2.9 Shanghai Medicilon
    • 2.9.1 Shanghai Medicilon Details
    • 2.9.2 Shanghai Medicilon Major Business
    • 2.9.3 Shanghai Medicilon Drug Preclinical CRO Services Product and Solutions
    • 2.9.4 Shanghai Medicilon Drug Preclinical CRO Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Shanghai Medicilon Recent Developments and Future Plans
  • 2.10 PharmaLegacy Laboratories
    • 2.10.1 PharmaLegacy Laboratories Details
    • 2.10.2 PharmaLegacy Laboratories Major Business
    • 2.10.3 PharmaLegacy Laboratories Drug Preclinical CRO Services Product and Solutions
    • 2.10.4 PharmaLegacy Laboratories Drug Preclinical CRO Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 PharmaLegacy Laboratories Recent Developments and Future Plans
  • 2.11 ChemPartner PharmaTech
    • 2.11.1 ChemPartner PharmaTech Details
    • 2.11.2 ChemPartner PharmaTech Major Business
    • 2.11.3 ChemPartner PharmaTech Drug Preclinical CRO Services Product and Solutions
    • 2.11.4 ChemPartner PharmaTech Drug Preclinical CRO Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 ChemPartner PharmaTech Recent Developments and Future Plans
  • 2.12 Crown Bioscience
    • 2.12.1 Crown Bioscience Details
    • 2.12.2 Crown Bioscience Major Business
    • 2.12.3 Crown Bioscience Drug Preclinical CRO Services Product and Solutions
    • 2.12.4 Crown Bioscience Drug Preclinical CRO Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Crown Bioscience Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Drug Preclinical CRO Services Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Drug Preclinical CRO Services by Company Revenue
    • 3.2.2 Top 3 Drug Preclinical CRO Services Players Market Share in 2025
    • 3.2.3 Top 6 Drug Preclinical CRO Services Players Market Share in 2025
  • 3.3 Drug Preclinical CRO Services Market: Overall Company Footprint Analysis
    • 3.3.1 Drug Preclinical CRO Services Market: Region Footprint
    • 3.3.2 Drug Preclinical CRO Services Market: Company Product Type Footprint
    • 3.3.3 Drug Preclinical CRO Services Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Drug Preclinical CRO Services Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Drug Preclinical CRO Services Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Drug Preclinical CRO Services Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Drug Preclinical CRO Services Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Drug Preclinical CRO Services Consumption Value by Type (2021-2032)
  • 6.2 North America Drug Preclinical CRO Services Market Size by Application (2021-2032)
  • 6.3 North America Drug Preclinical CRO Services Market Size by Country
    • 6.3.1 North America Drug Preclinical CRO Services Consumption Value by Country (2021-2032)
    • 6.3.2 United States Drug Preclinical CRO Services Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Drug Preclinical CRO Services Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Drug Preclinical CRO Services Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Drug Preclinical CRO Services Consumption Value by Type (2021-2032)
  • 7.2 Europe Drug Preclinical CRO Services Consumption Value by Application (2021-2032)
  • 7.3 Europe Drug Preclinical CRO Services Market Size by Country
    • 7.3.1 Europe Drug Preclinical CRO Services Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Drug Preclinical CRO Services Market Size and Forecast (2021-2032)
    • 7.3.3 France Drug Preclinical CRO Services Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Drug Preclinical CRO Services Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Drug Preclinical CRO Services Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Drug Preclinical CRO Services Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Drug Preclinical CRO Services Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Drug Preclinical CRO Services Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Drug Preclinical CRO Services Market Size by Region
    • 8.3.1 Asia-Pacific Drug Preclinical CRO Services Consumption Value by Region (2021-2032)
    • 8.3.2 China Drug Preclinical CRO Services Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Drug Preclinical CRO Services Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Drug Preclinical CRO Services Market Size and Forecast (2021-2032)
    • 8.3.5 India Drug Preclinical CRO Services Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Drug Preclinical CRO Services Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Drug Preclinical CRO Services Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Drug Preclinical CRO Services Consumption Value by Type (2021-2032)
  • 9.2 South America Drug Preclinical CRO Services Consumption Value by Application (2021-2032)
  • 9.3 South America Drug Preclinical CRO Services Market Size by Country
    • 9.3.1 South America Drug Preclinical CRO Services Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Drug Preclinical CRO Services Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Drug Preclinical CRO Services Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Drug Preclinical CRO Services Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Drug Preclinical CRO Services Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Drug Preclinical CRO Services Market Size by Country
    • 10.3.1 Middle East & Africa Drug Preclinical CRO Services Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Drug Preclinical CRO Services Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Drug Preclinical CRO Services Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Drug Preclinical CRO Services Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Drug Preclinical CRO Services Market Drivers
  • 11.2 Drug Preclinical CRO Services Market Restraints
  • 11.3 Drug Preclinical CRO Services Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Drug Preclinical CRO Services Industry Chain
  • 12.2 Drug Preclinical CRO Services Upstream Analysis
  • 12.3 Drug Preclinical CRO Services Midstream Analysis
  • 12.4 Drug Preclinical CRO Services Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Drug Preclinical CRO Services market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Drug Preclinical CRO Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Drug Preclinical CRO Services market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Drug Preclinical CRO Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Drug Preclinical CRO Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Drug Preclinical CRO Services market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Drug Preclinical CRO Services
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Drug Preclinical CRO Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include LabCorp, IQVIA, PPD, ICON（PRA）, Charles River, WuXi AppTec, Pharmaron, Joinn Laboratories, Shanghai Medicilon, PharmaLegacy Laboratories, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Drug Preclinical CRO Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Pharmacodynamic evaluation service
    Pharmacokinetic Evaluation Service
    Market segment by Application
    Biopharmaceutical Company
    Scientific Research Unit
    Market segment by players, this report covers
    LabCorp
    IQVIA
    PPD
    ICON（PRA）
    Charles River
    WuXi AppTec
    Pharmaron
    Joinn Laboratories
    Shanghai Medicilon
    PharmaLegacy Laboratories
    ChemPartner PharmaTech
    Crown Bioscience
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Drug Preclinical CRO Services product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Drug Preclinical CRO Services, with revenue, gross margin, and global market share of Drug Preclinical CRO Services from 2021 to 2026.
    Chapter 3, the Drug Preclinical CRO Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Drug Preclinical CRO Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Drug Preclinical CRO Services.
    Chapter 13, to describe Drug Preclinical CRO Services research findings and conclusion.

    Buy now